U.S. Chemicals Stock News

Electronic Arts stock in focus after recent share performance Electronic Arts (EA) has attracted fresh attention after recent share moves, with the stock showing a small 1 day decline and modest shifts over the past week, month and past 3 months. See our latest analysis for Electronic Arts. Those short term share price moves sit against a much stronger backdrop, with Electronic Arts posting a 1 year total shareholder return of 30.98% and a 5 year total shareholder return of 47.34%, suggesting...

Gartner, Inc. reported past first-quarter 2026 results with revenue of US$1.51 billion, net income of US$222.34 million, and diluted EPS from continuing operations of US$3.18, alongside continued share repurchases under its long-running buyback program. Following this stronger-than-expected quarter, Gartner raised its full-year outlook for adjusted profitability and free cash flow and expanded its equity repurchase authorization to US$8.10 billion, highlighting management’s focus on capital...

In April 2026, Raymond James Financial, Inc. reported second-quarter revenue of US$4,262 million and net income of US$544 million, with both metrics higher than a year earlier and earnings per share rising on both a basic and diluted basis. Alongside this earnings release, the company confirmed it had completed a US$500 million share repurchase program, retiring 3,191,170 shares, which can enhance earnings per share by spreading profits over a smaller share count. Next, we’ll examine how...

AutoNation (AN) just reported first quarter 2026 results that combined softer revenue and unit sales with its fifth straight quarter of year over year adjusted EPS growth, highlighting earnings support from higher margin operations. See our latest analysis for AutoNation. The 1-year total shareholder return of 15.25% and 5-year total shareholder return of 93.73% contrast with a modest year-to-date share price return decline of 1.85%, suggesting momentum has cooled even as recent earnings and...

Zoom Communications (NasdaqGS:ZM) has appointed former Microsoft executive Russell Dicker as Chief Product Officer to lead an AI focused transformation across its product suite. The company has also launched the "Solopreneur 50" program, spotlighting independent founders who are building AI powered businesses on Zoom. For investors tracking Zoom Communications at a share price of $106.63, these moves come alongside a period of strong recent share price momentum. The stock is up 17.4% over...

Why Fresh Del Monte Produce (FDP) is back in focus Fresh Del Monte Produce (FDP) is on investors’ radar after first quarter earnings showed sales of US$1,044.1 million and net income of US$10 million, both lower than the prior year period. See our latest analysis for Fresh Del Monte Produce. The latest set of results and the dividend affirmation arrive after a mixed share price pattern. A 14.24% year-to-date share price return alongside a 24.75% one-year total shareholder return suggests that...

If you are wondering whether PayPal Holdings at around US$50 per share is a bargain or a value trap, the key is to look closely at what the current price implies about its future. The stock recently closed at US$50.39, with returns of 1.2% over the last week and 11.1% over the last month, while the year to date return stands at a 13.3% decline and the one year return at a 26.1% decline. Recent coverage has focused on PayPal's position in digital payments and how competitive pressures and...

If you are wondering whether Equifax stock offers value at its current price, or if it is still pricing in too much past optimism, this article breaks down what the numbers are actually saying. The stock last closed at US$172.24, with returns of 1.0% over the past week, a 5.6% decline over the past month, and year to date and 1 year returns of 19.5% and 33.8% declines respectively. These figures may affect how you think about both risk and potential reward. Recent headlines around Equifax...

Earnings reversal puts Stepan’s latest quarter in focus Stepan (SCL) is back on investors’ radar after first quarter 2026 results showed sales of US$604.51 million alongside a net loss of US$41.41 million, compared with net income a year earlier. See our latest analysis for Stepan. The shares have softened around the earnings release, with a 1-day share price return of a 1.55% decline and a 7-day share price return of a 3.55% decline. The 1-year total shareholder return of a 2.19% decline and...

Wondering whether Plains GP Holdings is still reasonably priced after its strong run, or if expectations have gone too far? This breakdown will help you frame the stock's current value against its fundamentals. The stock last closed at US$24.23, with returns of 3.6% over 7 days, 0.7% over 30 days, 24.8% year to date and 52.0% over the past year, plus 128.0% over 3 years and 247.1% over 5 years. Recent coverage has focused on Plains GP Holdings as an established player in the midstream energy...

Bio-Techne stock: recent performance snapshot Bio-Techne (TECH) has drawn investor attention after a mixed stretch, with a small gain over the past month alongside a decline over the past 3 months and weaker multi year total returns. Against that backdrop, the stock last closed at US$54.74, with annual revenue of US$1.22b and net income of US$81.06m. This positions the company as a mid cap player in life science tools and diagnostics. See our latest analysis for Bio-Techne. Short term...

Wondering if Teva Pharmaceutical Industries at around US$35.35 is still offering value or if most of the opportunity has already been reflected in the price? This article breaks down what the current valuation signals are really saying. The stock has posted returns of 13.1% over the past week, 17.5% over the last month, 14.2% year to date and 115.7% over the past year, with a very large 3 year gain and a 244.9% 5 year return that naturally raise questions about risk and reward at today’s...

Compass (NYSE:COMP) agreed to acquire a 51% controlling stake in a venture, expanding its influence over a key part of its residential real estate platform. The company also entered a three year alliance with Rocket to broaden its home listing inventory and give agents access to a wider set of buyer and seller opportunities. At the same time, Compass continues to face federal price fixing litigation that introduces ongoing legal and operational uncertainty for the business. Compass focuses...

H2O America stock: overview and recent performance H2O America (HTO) has drawn fresh attention after its recent name change from SJW Group in May 2025. This has prompted investors to reassess how the stock’s returns and fundamentals stack up today. The utility provider, focused on water and related services in the United States, recently closed at $57.32. Over the past month the stock shows a return of a 3.1% decline, while the past 3 months reflect an 8.8% gain and the year-to-date figure...

This article looks at whether Novavax, trading at around US$8.03, is attractively priced or potentially a value trap, by exploring what the current price may be implying about the stock. The stock has seen mixed returns, with a 0.5% decline over the last 7 days, a 4.3% gain over 30 days, 12.6% year to date, 28.1% over 1 year, 7.8% over 3 years and a 95.0% loss over 5 years. Recent headlines around Novavax have kept the stock in focus, particularly as investors reassess its prospects beyond...

The United States market remained flat over the last week, yet it has seen a significant rise of 28% over the past year, with earnings expected to grow by 16% annually. In this environment, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation potential and robust financial health to capitalize on these favorable conditions.

Over the last 7 days, the United States market has remained flat, yet it has seen a significant rise of 28% over the past year, with earnings projected to grow by 16% annually in the coming years. In such an environment, identifying stocks that are trading below their intrinsic value can offer potential opportunities for investors seeking to capitalize on undervaluation.

The United States market remained flat over the last week, yet it has experienced a significant 28% rise over the past 12 months with earnings projected to grow by 16% annually. In this environment, growth companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those who know the business best.

The market remained flat over the last week, though it has risen 28% over the past year with earnings expected to grow by 16% annually. For investors willing to explore beyond well-known names, penny stocks—often representing smaller or newer companies—can still offer surprising value and potential for growth. In this article, we examine three penny stocks that combine financial strength with promising prospects in today's evolving market landscape.

Over the last 7 days, the United States market has remained flat, yet it is up 28% over the past year with earnings forecasted to grow by 16% annually. In this dynamic environment, identifying stocks that are not only resilient but also poised for growth can uncover potential opportunities in lesser-known companies.

Over the last 7 days, the United States market has remained flat, yet it has experienced a substantial 28% rise over the past year. In this context of expected earnings growth of 16% per annum in the coming years, identifying dividend stocks that offer consistent payouts and potential for capital appreciation becomes crucial for investors seeking stability and income.

Why Knife River’s latest earnings matter for shareholders Knife River (KNF) reported first quarter revenue of US$410.1 million and a net loss of US$79.2 million, a combination that often prompts investors to reassess how the stock reflects the underlying business. See our latest analysis for Knife River. The earnings update and the recent disclosure that Vanguard Capital Management holds 5.25% of Knife River appear to sit alongside strong recent momentum, with a 30 day share price return of...

Ultra Clean Holdings recently reported first-quarter 2026 results, with revenue rising to US$533.7 million while posting a net loss of US$17.9 million, and concurrently announced the upcoming retirement of CFO Sheri Savage alongside a change in board chair later this month. The company also issued second-quarter guidance calling for higher revenue and a return to GAAP profitability and disclosed new insider trading plans and a Form 144 filing, adding fresh context to its capital structure...

Immunome has submitted a New Drug Application to the FDA for varegacestat, an oral once-daily gamma secretase inhibitor for adults with desmoid tumors, backed by a global Phase 3 RINGSIDE trial that met its primary and key secondary endpoints. A key insight is that RINGSIDE is the largest randomized study conducted in this rare tumor type, with data selected for oral presentation at the 2026 ASCO Annual Meeting, highlighting the clinical community’s interest in varegacestat’s profile. We’ll...